Spacelabs Healthcare Introduces CardioPulse ECG Solutions for a Faster Path to Patient Care

Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), today announced the release of CardioPulse™ Go and CardioPulse™ Prime resting Electrocardiograph (ECG) devices.

“Workflow fit is a critical factor for clinicians when choosing resting ECG devices,” said Spacelabs President Shalabh Chandra. “Keeping this need in mind, Spacelabs Healthcare is pleased to introduce CardioPulse Go and CardioPulse Prime resting ECG carts to the U.S. market.”

Both new devices feature capabilities such as up to date orders lists, continuous connectivity and patient data query (PDQ) making them highly efficient even in the most acute settings. With a bi-directional DICOM option, results are instantly available in the Electronic Medical Record (EMR), Picture Archiving and Communication System (PACS) or ECG management systems. This translates to a faster path to patient care for providers.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”